RLX RLX Technology Inc. Annual reports only
Cigarettes · NYSE · SEC CIK 1828365 · Reporting currency CNY · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 · CNY | FY20242024-12-31 · CNY | FY20232023-12-31 · CNY | FY20222022-12-31 · CNY | FY20212021-12-31 · CNY |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | 3.96B | 2.75B | 1.59B | 5.33B | 8.52B |
| Cost of revenue | 2.43B | 1.72B | 856.33M | 2.97B | 4.85B |
| Gross profit | 1.18B | 726.52M | 387.71M | 2.31B | 3.67B |
| R&D expense | 131.01M | 88.31M | 172.69M | 317.11M | 179.91M |
| SG&A expense | 336.92M | 515.89M | 498.01M | 576.81M | 672.75M |
| Operating income | 328.56M | -107.14M | -496.71M | 1.06B | 2.30B |
| Interest expense | 6.39M | 176,000 | — | 1.40M | — |
| Pretax income | 1.05B | 658.80M | 591.74M | 1.78B | 2.66B |
| Income tax | 118.99M | 94.46M | 50.76M | 371.58M | 631.43M |
| Net income | 921.87M | 551.84M | 534.33M | 1.44B | 2.02B |
| EBITDA | 359.44M | -79.41M | -459.09M | 1.14B | 2.34B |
| EPS (basic) | 0.70 | 0.45 | 0.41 | 1.09 | 1.45 |
| EPS (diluted) | 0.70 | 0.43 | 0.40 | 1.08 | 1.44 |
| Dividends declared per share | 0.11USD | — | — | — | — |
| Weighted avg. shares (diluted) | 1.22B | 1.29B | 1.34B | 1.33B | 1.41B |
| Balance sheet | |||||
| Cash & equivalents | 5.37B | 5.59B | 2.39B | 1.29B | 5.21B |
| Short-term investments | 2.33B | 719.75M | 3.09B | 2.43B | 3.62B |
| Receivables | — | — | — | 51.38M | 12.49M |
| Inventory | 297.68M | 142.55M | 144.85M | 130.90M | 589.09M |
| Current assets | 11.20B | 9.30B | 8.98B | 11.20B | 13.95B |
| PP&E, net | 245.98M | 50.79M | 77.36M | 87.87M | 143.16M |
| Goodwill | 567.18M | 59.58M | 66.51M | — | — |
| Intangibles | 213.14M | 52.80M | 69.78M | 7.55M | 8.37M |
| Total assets | 17.93B | 16.87B | 16.32B | 16.38B | 16.37B |
| Current liabilities | 1.97B | 857.85M | 668.67M | 789.83M | 2.74B |
| Short-term debt | 92.10M | 40.00M | 0 | — | — |
| Total liabilities | 2.20B | 881.10M | 716.68M | 838.45M | 2.85B |
| Shareholders' equity | 15.63B | 15.99B | 15.61B | 15.57B | 13.51B |
| Shares outstanding | — | — | — | 1.53B | 1.57B |
| Cash flow statement | |||||
| Operating cash flow | 1.10B | 854.35M | 198.70M | 486.83M | 1.80B |
| Capital expenditure | 117.73M | 10.09M | 28.22M | 38.64M | 130.94M |
| Free cash flow | 986.82M | 844.26M | 170.48M | 448.19M | 1.67B |
| Investing cash flow | -822.19M | 3.02B | 2.09B | -4.13B | -7.87B |
| Financing cash flow | -282.75M | -678.03M | -1.19B | -477.27M | 9.90B |
| Depreciation & amortization | 30.88M | 27.74M | 37.62M | 76.04M | 40.87M |
| Stock-based compensation | 186.24M | 369.65M | 362.87M | 166.16M | 223.34M |
| Dividends paid | 91.47M | 88.84M | 92.38M | — | — |
| Share buybacks | 183.93M | 589.36M | 996.63M | 500.37M | 127.52M |
Free plan shows the latest 5 periods; Pro shows all 8 🔒
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· This company uses different currencies across periods or line items (e.g. USD convenience translations in annual reports). Each column header shows its currency and cells in a different currency are marked; do not compare figures across currencies. Charts use only periods in the latest period's currency.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.